Terms: = Cervical cancer AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184 AND Treatment
22 results:
1. An Immune Gene Expression Risk Score for Distant Metastases after Radiotherapy for cervical cancer.
Lukovic J; Pintilie M; Han K; Fyles AW; Bruce JP; Quevedo R; Pugh TJ; Fjeldbo CS; Lyng H; Milosevic MF
Clin Cancer Res; 2024 Mar; 30(6):1200-1207. PubMed ID: 38180733
[TBL] [Abstract] [Full Text] [Related]
2. Human papillomavirus in the setting of immunodeficiency: Pathogenesis and the emergence of next-generation therapies to reduce the high associated cancer risk.
Hewavisenti RV; Arena J; Ahlenstiel CL; Sasson SC
Front Immunol; 2023; 14():1112513. PubMed ID: 36960048
[TBL] [Abstract] [Full Text] [Related]
3. The prognostic significance of cxcr4 and SDF-1 in differentiated thyroid cancer depends on CD8+ density.
Wilhelm A; Lemmenmeier I; Lalos A; Posabella A; Kancherla V; Piscuoglio S; Delko T; von Flüe M; Glatz K; Droeser RA
BMC Endocr Disord; 2022 Nov; 22(1):292. PubMed ID: 36419107
[TBL] [Abstract] [Full Text] [Related]
4. The CXCL12/CXCR7 signalling axis promotes proliferation and metastasis in cervical cancer.
Xu L; Li C; Hua F; Liu X
Med Oncol; 2021 Apr; 38(5):58. PubMed ID: 33847822
[TBL] [Abstract] [Full Text] [Related]
5. The Oral cxcr4 Inhibitor X4-136 Improves Tumor Control and Reduces Toxicity in cervical cancer Treated With Radiation Therapy and Concurrent Chemotherapy.
Chaudary N; Hill RP; Stulik L; Milosevic M
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1317-1324. PubMed ID: 33771702
[TBL] [Abstract] [Full Text] [Related]
6. Preparation Of Nanobubbles Modified With A Small-Molecule cxcr4 Antagonist For Targeted Drug Delivery To Tumors And Enhanced Ultrasound Molecular Imaging.
Peng Y; Zhu L; Wang L; Liu Y; Fang K; Lan M; Shen D; Liu D; Yu Z; Guo Y
Int J Nanomedicine; 2019; 14():9139-9157. PubMed ID: 32063704
[TBL] [Abstract] [Full Text] [Related]
7. Targeting CXCL12/cxcr4 and myeloid cells to improve the therapeutic ratio in patient-derived cervical cancer models treated with radio-chemotherapy.
Lecavalier-Barsoum M; Chaudary N; Han K; Pintilie M; Hill RP; Milosevic M
Br J Cancer; 2019 Jul; 121(3):249-256. PubMed ID: 31239542
[TBL] [Abstract] [Full Text] [Related]
8. CXCL12 modulates the radiosensitivity of cervical cancer by regulating CD44.
Fu Z; Zhang P; Luo H; Huang H; Wang F
Mol Med Rep; 2018 Dec; 18(6):5101-5108. PubMed ID: 30320394
[TBL] [Abstract] [Full Text] [Related]
9. Targeting the CXCL12/cxcr4 pathway and myeloid cells to improve radiation treatment of locally advanced cervical cancer.
Lecavalier-Barsoum M; Chaudary N; Han K; Koritzinsky M; Hill R; Milosevic M
Int J Cancer; 2018 Sep; 143(5):1017-1028. PubMed ID: 29417588
[TBL] [Abstract] [Full Text] [Related]
10. O-GlcNAcylation of NF-κB Promotes Lung Metastasis of cervical cancer Cells via Upregulation of cxcr4 Expression.
Ali A; Kim SH; Kim MJ; Choi MY; Kang SS; Cho GJ; Kim YS; Choi JY; Choi WS
Mol Cells; 2017 Jul; 40(7):476-484. PubMed ID: 28681591
[TBL] [Abstract] [Full Text] [Related]
11. Cyclophosphamide promotes breast cancer cell migration through cxcr4 and matrix metalloproteinases.
Hung CM; Hsu YC; Chen TY; Chang CC; Lee MJ
Cell Biol Int; 2017 Mar; 41(3):345-352. PubMed ID: 28035725
[TBL] [Abstract] [Full Text] [Related]
12. CXCL12 is a key regulator in tumor microenvironment of cervical cancer: an in vitro study.
Yadav SS; Prasad SB; Prasad CB; Pandey LK; Pradhan S; Singh S; Narayan G
Clin Exp Metastasis; 2016 Jun; 33(5):431-9. PubMed ID: 26970955
[TBL] [Abstract] [Full Text] [Related]
13. MET receptor is a potential therapeutic target in high grade cervical cancer.
Miekus K; Pawlowska M; Sekuła M; Drabik G; Madeja Z; Adamek D; Majka M
Oncotarget; 2015 Apr; 6(12):10086-101. PubMed ID: 25888626
[TBL] [Abstract] [Full Text] [Related]
14. Baohuoside I suppresses invasion of cervical and breast cancer cells through the downregulation of cxcr4 chemokine receptor expression.
Kim B; Park B
Biochemistry; 2014 Dec; 53(48):7562-9. PubMed ID: 25407882
[TBL] [Abstract] [Full Text] [Related]
15. Epigenetic silencing of cxcr4 promotes loss of cell adhesion in cervical cancer.
Yadav SS; Prasad SB; Das M; Kumari S; Pandey LK; Singh S; Pradhan S; Narayan G
Biomed Res Int; 2014; 2014():581403. PubMed ID: 25114911
[TBL] [Abstract] [Full Text] [Related]
16. Oligomannurarate sulfate inhibits CXCL12/SDF-1-mediated proliferation and invasion of human tumor cells in vitro.
Wen WW; Xie S; Xin XL; Geng MY; Ding J; Chen Y
Acta Pharmacol Sin; 2013 Dec; 34(12):1554-9. PubMed ID: 24141568
[TBL] [Abstract] [Full Text] [Related]
17. Hypoxia and metastasis in an orthotopic cervix cancer xenograft model.
Chaudary N; Mujcic H; Wouters BG; Hill RP
Radiother Oncol; 2013 Sep; 108(3):506-10. PubMed ID: 23856487
[TBL] [Abstract] [Full Text] [Related]
18. Effect of a nitric oxide synthase inhibitor and a CXC chemokine receptor-4 antagonist on tumor growth and metastasis in a xenotransplanted mouse model of adenoid cystic carcinoma of the oral floor.
Takaoka K; Hidaka S; Hashitani S; Segawa E; Yamamura M; Tanaka N; Zushi Y; Noguchi K; Kishimoto H; Urade M
Int J Oncol; 2013 Sep; 43(3):737-45. PubMed ID: 23835861
[TBL] [Abstract] [Full Text] [Related]
19. SIVmac₂₃₉-Nef down-regulates cell surface expression of cxcr4 in tumor cells and inhibits proliferation, migration and angiogenesis.
Cai C; Rodepeter FR; Rossmann A; Teymoortash A; Lee JS; Quint K; DI Fazio P; Ocker M; Werner JA; Mandic R
Anticancer Res; 2012 Jul; 32(7):2759-68. PubMed ID: 22753736
[TBL] [Abstract] [Full Text] [Related]
20. [The role and mechanism of cxcr4 and its ligand SDF-1 in the development of cervical cancer metastasis].
Shen XY; Wang SH; Liang ML; Wang HB; Xiao L; Wang ZH
Ai Zheng; 2008 Oct; 27(10):1044-9. PubMed ID: 18851783
[TBL] [Abstract] [Full Text] [Related]
[Next]
